ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 716679 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 716679; 2) Community: the network communities that were significantly associated with the response to NSC 716679; 3) Molecule: the relationships between components within communities and NSC 716679; 4) MDR: the compounds that were significantly associated with the NSC 716679.

NSC Compound Enrichment Correlation
NSC 634784 4-Piperidinone, 1-[3-(dimethylamino)-1-oxopropyl]-3,5- bis(phenylmethylene)-, monohydrochloride 0.00396536695012845 0.56427166
NSC 646604 Null 0.00396536695012845 0.23125729
NSC 655105 Cycloshikonin 0.00396536695012845 0.51800245
NSC 686553 9H-Quino[4,3,2-de][1,10]phenanthrolin-9-one, 2-phenyl- 0.00396536695012845 0.41197635
NSC 687011 stereoisomer of 672120 (MW=262) 0.00396536695012845 0.63693884
NSC 702045 2-Propenone, 1,1'-(2,5-pyridinediyl)bis[3-(3,4-dimethoxyphenyl)- 0.00396536695012845 0.52934792
NSC 723906 1,4-di-N-oxide-6,7-difluor-2-phenylcarbonyl-3-trifluormethyl quinoxaline 0.00396536695012845 0.49734335
NSC 72151 2H-1-Benzopyran-2-one, 6-[[4-[bis[2-[(methylsulfonyl)ethyl]amino]phenyl]methylene]amino]- (9CI) 0.00396536695012846 0.10329928
NSC 200692 Aspiculamycin hydrochloride 0.00526022686151163 -0.30631468
NSC 625498 4-Morpholinecarbodithioic acid, antimony complex 0.00526022686151163 0.42348084
Total:116  Current:24    [First] [Prev] [Next] [Last]